Skip to main content
Erschienen in: Tumor Biology 11/2016

14.09.2016 | Original Article

Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity

verfasst von: Xue-Song Wu, Tian-Hao Bao, Yang Ke, De-Yun Sun, Zhi-Tian Shi, Hao-Ran Tang, Lin Wang

Erschienen in: Tumor Biology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Histidine triad nucleotide-binding protein 1 (Hint1) is a haploinsufficient tumor suppressor gene. Its role in cancer cell migration has not been previously speculated. In the current study, we examined the expression of Hint1 in metastatic and non-metastatic lymph nodes of hepatocellular carcinoma (HCC) patients and further elucidated the effect of Hint1 expression on girdin expression and phosphorylation of AKT and ERK1/2 and on the migration of HCC cells in vitro. Expression of Hint1 and girdin in primary HCC tissues and metastatic and non-metastatic lymph nodes was determined by RT-PCR assays. HepG2 cells were transfected with plasmid vectors overexpressing Hint1 or small interfering RNA (siRNA) targeting Hint1, girdin, Hint1 plus girdin, or the scrambled RNA. Migration and invasion of HCC cells were examined by wound and Transwell assays. Protein expression was detected by immunofluorescence and immunoblotting assays. RT-PCR assays revealed that the messenger RNA (mRNA) transcript levels of Hint1 were markedly lower than those of primary HCC tissues and non-metastatic lymph nodes (P < 0.01). By contrast, the mRNA transcript levels of girdin were significantly higher than non-metastatic lymph nodes (P < 0.05). Furthermore, siRNA knockdown of HINT1 resulted in a significant increase in the mRNA transcript levels of girdin in HepG2 cells (P < 0.05). Wound assays and Transwell assays showed that Hint1 knockdown by siRNA significantly enhanced the migration and invasion of HepG2 cells compared to HepG2 cells transfected with scrambled siRNA. Hint1 knockdown also led to significantly increased phosphorylation of girdin and AKT in HepG2 cells (P < 0.05), which, however, was effectively aborted by girdin knockdown by siRNA (P < 0.05). Hint1 is downregulated in metastatic lymph nodes and is implicated in migration and invasion of HCC cells in vitro by modulating girdin and AKT expression and phosphorylation. The Hint1-girdin-AKT signaling axis should be further dissected for its role in HCC migration and invasion and may be therapeutically targeted to suppress tumor growth and metastasis.
Literatur
1.
Zurück zum Zitat Lu XJ, Shi Y, Chen JL, Ma S. Krüppel-like factors in hepatocellular carcinoma. Tumour Biol. 2015;36:533–41.CrossRefPubMed Lu XJ, Shi Y, Chen JL, Ma S. Krüppel-like factors in hepatocellular carcinoma. Tumour Biol. 2015;36:533–41.CrossRefPubMed
2.
Zurück zum Zitat Jin C, Ye QH, Yuan FL, Gu YL, Li JP, Shi YH, et al. Involvement of acid-sensing ion channel 1α in hepatic carcinoma cell migration and invasion. Tumour Biol. 2015;36:4309–17.CrossRefPubMed Jin C, Ye QH, Yuan FL, Gu YL, Li JP, Shi YH, et al. Involvement of acid-sensing ion channel 1α in hepatic carcinoma cell migration and invasion. Tumour Biol. 2015;36:4309–17.CrossRefPubMed
3.
Zurück zum Zitat Song R, Song H, Liang Y, Yin D, Zhang H, Zheng T, et al. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis. Hepatology. 2014;60:1659–73.CrossRefPubMed Song R, Song H, Liang Y, Yin D, Zhang H, Zheng T, et al. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis. Hepatology. 2014;60:1659–73.CrossRefPubMed
4.
Zurück zum Zitat Hasegawa K, Makuuchi M, Kokudo N, Izumi N, Ichida T, Kudo M, et al. Impact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma: report of a Japanese nationwide survey. Ann Surg. 2014;259:166–70.CrossRefPubMed Hasegawa K, Makuuchi M, Kokudo N, Izumi N, Ichida T, Kudo M, et al. Impact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma: report of a Japanese nationwide survey. Ann Surg. 2014;259:166–70.CrossRefPubMed
5.
Zurück zum Zitat Hsieh SC, Tsai JP, Yang SF, Tang MJ, Hsieh YH. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression. Amino Acids. 2014;46:2809–22.CrossRefPubMed Hsieh SC, Tsai JP, Yang SF, Tang MJ, Hsieh YH. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression. Amino Acids. 2014;46:2809–22.CrossRefPubMed
6.
Zurück zum Zitat Wu YJ, Neoh CA, Tsao CY, Su JH, Li HH. Sinulariolide suppresses human hepatocellular carcinoma cell migration and invasion by inhibiting matrix metalloproteinase-2/−9 through MAPKs and PI3K/akt signaling pathways. Int J Mol Sci. 2015;16:16469–82.CrossRefPubMedPubMedCentral Wu YJ, Neoh CA, Tsao CY, Su JH, Li HH. Sinulariolide suppresses human hepatocellular carcinoma cell migration and invasion by inhibiting matrix metalloproteinase-2/−9 through MAPKs and PI3K/akt signaling pathways. Int J Mol Sci. 2015;16:16469–82.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Li H, Zhang Y, Su T, Santella RM, Weinstein IB. Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene. 2006;25:713–21.CrossRefPubMed Li H, Zhang Y, Su T, Santella RM, Weinstein IB. Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene. 2006;25:713–21.CrossRefPubMed
8.
Zurück zum Zitat Wang L, Zhang Y, Li H, Xu Z, Santella RM, Weinstein IB. Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells. Cancer Res. 2007;67:4700–8.CrossRefPubMed Wang L, Zhang Y, Li H, Xu Z, Santella RM, Weinstein IB. Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells. Cancer Res. 2007;67:4700–8.CrossRefPubMed
9.
Zurück zum Zitat Enomoto A, Murakami H, Asai N, Morone N, Watanabe T, Kawai K, et al. Akt/PKB regulates actin organization and cell motility via girdin/APE. Dev Cell. 2005;9:389–402.CrossRefPubMed Enomoto A, Murakami H, Asai N, Morone N, Watanabe T, Kawai K, et al. Akt/PKB regulates actin organization and cell motility via girdin/APE. Dev Cell. 2005;9:389–402.CrossRefPubMed
10.
Zurück zum Zitat Zhang YJ, Li H, Wu HC, Shen J, Wang L, Yu MW, et al. Silencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinoma. Cancer Lett. 2009;275:277–84.CrossRefPubMed Zhang YJ, Li H, Wu HC, Shen J, Wang L, Yu MW, et al. Silencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinoma. Cancer Lett. 2009;275:277–84.CrossRefPubMed
11.
Zurück zum Zitat Enomoto A. Roles of DISC1-interacting protein girdin in postnatal development and adult neurogenesis in the dentate gyrus. Nihon Shinkei Seishin Yakurigaku Zasshi. 2011;31:23–8.PubMed Enomoto A. Roles of DISC1-interacting protein girdin in postnatal development and adult neurogenesis in the dentate gyrus. Nihon Shinkei Seishin Yakurigaku Zasshi. 2011;31:23–8.PubMed
12.
Zurück zum Zitat Zambelli D, Zuntini M, Nardi F, Manara MC, Serra M, Landuzzi L, et al. Biological indicators of prognosis in Ewing’s sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). Int J Cancer. 2010;126:41–52.CrossRefPubMed Zambelli D, Zuntini M, Nardi F, Manara MC, Serra M, Landuzzi L, et al. Biological indicators of prognosis in Ewing’s sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP). Int J Cancer. 2010;126:41–52.CrossRefPubMed
13.
Zurück zum Zitat Enomoto A, Asai N, Takahashi M. Mechanisms for the differentiation of postnatal and adult neural stem cells: new insights and pathological issues based on the analysis of girdin. Nihon Yakurigaku Zasshi. 2014;143:289–94.CrossRefPubMed Enomoto A, Asai N, Takahashi M. Mechanisms for the differentiation of postnatal and adult neural stem cells: new insights and pathological issues based on the analysis of girdin. Nihon Yakurigaku Zasshi. 2014;143:289–94.CrossRefPubMed
14.
Zurück zum Zitat Weng L, Enomoto A, Ishida-Takagishi M, Asai N, Takahashi M. Girding for migratory cues: roles of the Akt substrate girdin in cancer progression and angiogenesis. Cancer Sci. 2010;101:836–42.CrossRefPubMed Weng L, Enomoto A, Ishida-Takagishi M, Asai N, Takahashi M. Girding for migratory cues: roles of the Akt substrate girdin in cancer progression and angiogenesis. Cancer Sci. 2010;101:836–42.CrossRefPubMed
15.
Zurück zum Zitat Cao K, Lu C, Han S, Zou Q, Li J, Xie D, et al. Expression of girdin in primary hepatocellular carcinoma and its effect on cell proliferation and invasion. Int J Clin Exp Pathol. 2015;8:551–9.PubMedPubMedCentral Cao K, Lu C, Han S, Zou Q, Li J, Xie D, et al. Expression of girdin in primary hepatocellular carcinoma and its effect on cell proliferation and invasion. Int J Clin Exp Pathol. 2015;8:551–9.PubMedPubMedCentral
16.
Zurück zum Zitat Wang Y, Yuan L, Yang XM, Wei D, Wang B, Sun XX, et al. A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-girdin signaling pathway. Clin Exp Metastasis. 2015;32:39–53.CrossRefPubMed Wang Y, Yuan L, Yang XM, Wei D, Wang B, Sun XX, et al. A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-girdin signaling pathway. Clin Exp Metastasis. 2015;32:39–53.CrossRefPubMed
17.
Zurück zum Zitat Leyme A, Marivin A, Garcia-Marcos M. GIV/girdin (Gα-interacting, vesicle-associated protein/girdin) creates a positive feedback loop that potentiates outside-in integrin signaling in cancer cells. J Biol Chem. 2016;291:8269–82.CrossRefPubMed Leyme A, Marivin A, Garcia-Marcos M. GIV/girdin (Gα-interacting, vesicle-associated protein/girdin) creates a positive feedback loop that potentiates outside-in integrin signaling in cancer cells. J Biol Chem. 2016;291:8269–82.CrossRefPubMed
18.
Zurück zum Zitat Weiske J, Huber O. The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-beta-catenin-mediated transcription. J Cell Sci. 2005;118:3117–29.CrossRefPubMed Weiske J, Huber O. The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-beta-catenin-mediated transcription. J Cell Sci. 2005;118:3117–29.CrossRefPubMed
19.
Zurück zum Zitat Wang L, Li H, Zhang Y, Santella RM, Weinstein IB. HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB activity in human hepatoma cells. Int J Cancer. 2009;124:1526–34.CrossRefPubMedPubMedCentral Wang L, Li H, Zhang Y, Santella RM, Weinstein IB. HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB activity in human hepatoma cells. Int J Cancer. 2009;124:1526–34.CrossRefPubMedPubMedCentral
Metadaten
Titel
Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity
verfasst von
Xue-Song Wu
Tian-Hao Bao
Yang Ke
De-Yun Sun
Zhi-Tian Shi
Hao-Ran Tang
Lin Wang
Publikationsdatum
14.09.2016
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 11/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5336-z

Weitere Artikel der Ausgabe 11/2016

Tumor Biology 11/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.